EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Synergistic Effects of Curcumin and Antibiotics Against Drug-Sensitive and Multidrug-Resistant Mycobacterium tuberculosis

Jacqueline V Lara-Espinosa iD, Jorge Barrios-Payán iD, Vasti Lozano-Ordaz iD, Dulce Mata-Espinosa, Enrique Becerril-Villanueva iD, María Dolores Ponce-Regalado, Rogelio Hernández-Pando iD

International Journal of Molecular Sciences · 27.10.2025 · 26 (21) · 10414

DOI: 10.3390/ijms262110414 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 27.10.2025. Verfasst von Jacqueline V Lara-Espinosa und 6 weiteren Autor:innen. Beteiligte Einrichtung: Sección de Patología Experimental, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Vasco de Quiroga 15, Belisario Domínguez Secc…. Hauptthemen laut MEDLINE: Curcumin, Anti-Bacterial Agents, Tuberculosis, Multidrug-Resistant, Mycobacterium tuberculosis. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), remains a global health challenge, partly due to the prolonged duration and toxicity of standard antibiotic regimens. Adjunctive therapies that enhance antimicrobial efficacy and modulate host immunity are urgently needed. Curcumin, a natural bioactive compound derived from Curcuma longa, possesses broad therapeutic properties, including anti-inflammatory, antioxidant, antibacterial, and antiviral effects. This study evaluated the effects of curcumin in combination with first- and second-line antibiotics against Mtb in both in vitro and in vivo models. Our results demonstrated that curcumin exerts direct antibacterial activity against both the drug-sensitive H37Rv strain and a multidrug-resistant (MDR) clinical isolate. Furthermore, curcumin synergized with conventional antibiotics, enhancing bacterial clearance in infected macrophages while promoting the production of IL-12, a key cytokine in protective immune responses. In a murine model of progressive pulmonary TB, combination therapy with curcumin and first-line antibiotics significantly reduced the lung bacterial burden and improved behavioral outcomes compared to antibiotic treatment alone. These findings suggest that curcumin acts through both direct antimicrobial mechanisms and immune modulation, supporting its potential as an adjunctive therapy agent for TB. Future studies should focus on optimizing curcumin formulation, dosing, and bioavailability to facilitate the clinical translation of this compound.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CurcuminAnti-Bacterial AgentsTuberculosis, Multidrug-ResistantMycobacterium tuberculosisDrug Resistance, Multiple, BacterialDrug SynergismDrug Therapy, CombinationMicrobial Sensitivity TestsMacrophagesAnimalsMiceDisease Models, AnimalMaleMice, Inbred BALB CBacterial LoadLung

Stichwörter der Autor:innen

MDR-TBadjunctive therapyantibiotic synergycurcumintuberculosis

Substanzen

CurcuminAnti-Bacterial Agents

Autor:innen und Institutionen

  • Sección de Patología Experimental, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Vasco de Quiroga 15, Belisario Domínguez Sección 16, Tlalpan, Ciudad de México 14080, Mexico.
  • Laboratorio de Psicoinmunología, Instituto Nacional de Psiquiatría Ramon de la Fuente Muñiz, Calzada México-Xochimilco 101, Colonia, Huipulco, Tlalpan, Ciudad de México 14370, Mexico.
  • Departamento de Ciencias de la Salud, Centro Universitario de los Altos, Universidad de Guadalajara, Av Rafael Casillas Aceves 120, Tepatitlán de Morelos 47620, Jalisco, Mexico.

ORCID-Profile: Jacqueline V Lara-Espinosa, Jorge Barrios-Payán, Vasti Lozano-Ordaz, Enrique Becerril-Villanueva, Rogelio Hernández-Pando

Zitieren

APA

Lara-Espinosa, J. V., Barrios-Payán, J., Lozano-Ordaz, V., Mata-Espinosa, D., Becerril-Villanueva, E., Ponce-Regalado, M. D., & Hernández-Pando, R. (2025). Synergistic Effects of Curcumin and Antibiotics Against Drug-Sensitive and Multidrug-Resistant Mycobacterium tuberculosis. International Journal of Molecular Sciences, 26(21), 10414. https://doi.org/10.3390/ijms262110414

Vancouver

Lara-Espinosa JV, Barrios-Payán J, Lozano-Ordaz V, Mata-Espinosa D, Becerril-Villanueva E, Ponce-Regalado MD, et al. Synergistic Effects of Curcumin and Antibiotics Against Drug-Sensitive and Multidrug-Resistant Mycobacterium tuberculosis. International Journal of Molecular Sciences. 2025;26(21):10414. doi:10.3390/ijms262110414

BibTeX
@article{LaraEspinosa2025,
  author = {Lara-Espinosa, Jacqueline V and Barrios-Payán, Jorge and Lozano-Ordaz, Vasti and Mata-Espinosa, Dulce and Becerril-Villanueva, Enrique and Ponce-Regalado, María Dolores and Hernández-Pando, Rogelio},
  title = {Synergistic Effects of Curcumin and Antibiotics Against Drug-Sensitive and Multidrug-Resistant Mycobacterium tuberculosis},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {21},
  pages = {10414},
  doi = {10.3390/ijms262110414}
}
Kostenlos starten →